Advancing Healthcare
through Innovation
e·merge / əˈmərj /    become apparent, important, or prominent
E-merge Capital Partners is a venture capital and growth equity firm dedicated to investing in innovative, early-stage medical device companies and technologies to improve quality of life
Access
We have significant access to medical device experts, physicians, industry and venture funds.
Our network of advisors provides best-in-class expertise to assist with evaluating and de-risking new opportunities and supporting our portfolio companies.
Experience
Our team has 100+ years of medical device, general business and venture investing experience.
We have encountered and solved many of the challenges that early-stage medical device companies face and understand how strategic buyers and partners think.
Network
Our network provides access to experienced and cost-effective vendors and consultants where strong relationships exist including personal relationships with strategic buyers and key clinicians.
E-merge Capital Partners Launches Venture Capital Fund Dedicated to Early-Stage Medical Device Products and Companies
May 19, 2021 — E-merge Capital Partners (E-merge) today announced the first closing of investments in its venture fund (E-merge Fund I) focused on early-stage medical device companies and technologies.
The E-merge team brings decades of medical device and venture investing experience, as well as diverse entrepreneurial backgrounds, to the new venture. The firm will be led by Managing Partners Brad Klos and John M. Xitco, and Venture Partners Randy Werneth and Rob Abrams. Read more…
News & Recent Events
